[The increase of insulin sensitivity with ganglionic-blocking agents in insulin shock therapy. I. Hexamethon].
D003295:Convulsive Therapy; D006584:Hexamethonium Compounds; D006801:Humans; D007328:Insulin; D007331:Insulin Coma; D007333:Insulin Resistance
D006584:Hexamethonium Compounds; D007328:Insulin
HEXAMETHONIUM COMPOUNDS; SHOCK THERAPY, INSULIN